Objectives: Many cellular functions are controlled by cell-cell and cell-ma
trix interactions. It has recently been found that syndecans, transmembrane
heparan sulphate (HS) proteoglycans, can act as receptors or coreceptors a
nd modulate cell adhesion. Our aim was to study the role of syndecan-1 in t
he aggregation of human lymphoma cells, and to investigate its effect on ce
ll survival. Methods: Immunocytochemistry, confocal laser scanning microsco
py, flow cytometry and aggregation/reaggregation bio-assays were used on HT
58, BL41/95 and Raji lymphoma cell lines. Results: Bio-assays showed that t
he aggregation of HT58 cells was inhibited by heparin, HS, removal of the H
S chain and binding of the anti-syndecan-1 monoclonal antibody. In the sear
ch for a counter-receptor of syndecan-1, several adhesion molecules were te
sted, but none of them proved to be the adhesion partner. In the case of he
paritinase/trypsin digestion with long-term inhibition of HS synthesis (sod
ium chlorate treatment), the inhibited aggregation was accompanied by cell
cycle arrest and the induction of apoptosis. Conclusions: The results obtai
ned showed that surface syndecan-1 expression contributes to homotypic adhe
sion. In addition, HS chains, including those on syndecan-1, take part in t
he regulation of cell proliferation and active cell death in HT58 lymphoma
cells. Copyright (C) 2000 S. Karger AG. Basel.